查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595556

临床前医疗设备测试服务市场：按服务、按阶段划分 - 2025-2030 年全球预测

Preclinical Medical Device Testing Services Market by Service (Antimicrobial Activity Testing, Bioburden Determination, Biocompatibility Test), Phase (Antimicrobial Wound Dressings, Medical Coatings) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年临床前医疗设备测试服务市值为65.4亿美元，预计到2024年将达到73.4亿美元，复合年增长率为12.66%，到2030年将达到150.7亿美元，预计将达到1000万美元。

临床前医疗设备测试服务对于确保医疗设备在进入临床试验之前的安全性和有效性至关重要。这包括透过各种方法评估生物相容性、功能和性能，包括体外和体内测试。对这些服务的需求源于严格的监管合规要求以及减少与医疗设备故障相关的潜在风险的需要。临床前测试的应用很广泛，涵盖植入设备、诊断设备和手术器械等设备类别。最终用途范围主要包括医疗设备製造商、研究机构和热衷于器材检验和安全保证的监管机构。市场成长的主要动力是创新医疗技术研发投资的增加、监管力度的加强以及需要先进医疗解决方案的慢性病盛行率的上升。此外，材料科学和生物标记技术的进步带来了成长机会。然而，市场扩张面临挑战，例如与全面测试流程相关的高成本以及由于监管核准可能出现的延误，这可能会拖累预算有限的中小型企业。此外，不断变化的法规给市场相关人员带来了合规挑战。开发具有成本效益的调查方法以及整合人工智慧和机器学习以进行预测分析和高效试验设计的机会比比皆是。此外，专注于穿戴式医疗设备等特定细分市场可提供巨大的成长潜力。为了利用这些机会，企业应优先投资最尖端科技，并加强与学术和研究机构的合作，以提高测试能力。儘管竞争激烈，但持续的创新和对技术进步的适应推动了市场的成功，使我们能够有效应对复杂的法规环境，同时满足日益增长的医疗设备测试需求。

主要市场统计
基准年[2023] 65.4亿美元
预测年份 [2024] 73.4亿美元
预测年份 [2030] 150.7亿美元
复合年增长率（%） 12.66%

市场动态：快速发展的临床前医疗设备测试服务市场的关键市场洞察

临床前医疗设备测试服务市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 对医疗设备验证和检验的需求不断增加
    • 政府对医疗基础设施发展的积极努力和投资
    • 外包医疗设备检测服务需求快速成长
  • 市场限制因素
    • 有限的基础设施和复杂的服务
  • 市场机会
    • 物联网和人工智慧在各种医疗设备中的发展
    • 医疗设备检测服务的技术进步与创新
  • 市场挑战
    • 对海外标准化资格考试的担忧

波特五力：驾驭临床前医疗设备测试服务市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解临床前医疗设备测试服务市场的外部影响

外部宏观环境因素在塑造临床前医疗设备测试服务市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解临床前医疗设备测试服务市场的竞争格局

临床前医疗设备测试服务市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵临床前医疗设备测试服务市场供应商的绩效评估

FPNV 定位矩阵是评估临床前医疗设备测试服务市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了临床前医疗设备测试服务市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，临床前医疗设备测试服务市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对医疗设备检验和检验的需求不断增加
      • 政府对医疗基础设施发展的有利措施和投资
      • 医疗设备检测服务外包需求快速成长
    • 抑制因素
      • 基础设施设置有限且服务复杂
    • 机会
      • IoT/AI在各种医疗设备中的发展
      • 医疗设备检测服务的技术进步与创新
    • 任务
      • 海外统一资格考试的担忧
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章临床前医疗设备测试服务市场：依服务分类

  • 抗菌活性测试
  • 微生物附着量测量
  • 生物相容性测试
  • 化学测试
  • 微生物测试和无菌
  • 热原和内毒素检测
  • 无菌测试和检验

第七章临床前医疗设备检测服务市场分阶段

  • 抗菌伤口敷料
  • 医用涂层

第八章美洲临床前医疗设备测试服务市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区临床前医疗设备测试服务市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲临床前医疗设备测试服务市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Bureau Veritas SA
  • Charles River Laboratories, Inc.
  • Eurofins Scientific（Ireland）Limited
  • Intertek Group PLC
  • Medistri SA
  • Nelson Labs NV
  • PaxeraHealth LLC
  • Pharmacology Discovery Services Taiwan, Ltd.
  • SGS Societe Generale de Surveillance SA
  • Sipra Labs Limited
  • Sterigenics International LLC
  • TUV Rheinland AG
  • UL LLC
  • Viroclinics Biosciences
  • WuXi AppTec Co., Ltd.
Product Code: MRR-3A2E844FD678

The Preclinical Medical Device Testing Services Market was valued at USD 6.54 billion in 2023, expected to reach USD 7.34 billion in 2024, and is projected to grow at a CAGR of 12.66%, to USD 15.07 billion by 2030.

Preclinical medical device testing services are critical in ensuring the safety and efficacy of medical devices before they reach clinical trials. This involves assessments of biocompatibility, functionality, and performance through various methods such as in vitro and in vivo studies. The necessity of these services stems from the demand for stringent regulatory compliance and the need to mitigate potential risks associated with medical device failures. Applications of preclinical testing are wide-ranging, covering device categories like implantable devices, diagnostic equipment, and surgical instruments. The end-use scope primarily includes medical device manufacturers, research institutions, and regulatory bodies keen on device validation and safety assurance. Market growth is primarily driven by increasing R&D investments in innovative medical technologies, heightened regulatory scrutiny, and the rising prevalence of chronic diseases that necessitate advanced medical solutions. Moreover, advances in materials science and biomarker technologies present lucrative opportunities for growth. However, market expansion faces challenges such as high costs associated with comprehensive testing processes and potential delays due to regulatory approvals, which can deter smaller companies with budget constraints. Additionally, evolving regulations pose a compliance challenge for market players. Opportunities abound in the development of cost-effective testing methodologies and the integration of AI and machine learning for predictive analytics and efficient test designs. Moreover, focusing on specific segments like wearable medical devices can provide substantial growth potential. To capitalize on these opportunities, companies should prioritize investing in cutting-edge technologies and foster collaborations with academic and research institutions to enhance testing capabilities. Despite the competitive landscape, continuous innovation and adaptation to technological advancements will likely drive market success, positioning companies to effectively navigate the complexities of regulatory environments while meeting growing demands for medical device testing.

KEY MARKET STATISTICS
Base Year [2023] USD 6.54 billion
Estimated Year [2024] USD 7.34 billion
Forecast Year [2030] USD 15.07 billion
CAGR (%) 12.66%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Preclinical Medical Device Testing Services Market

The Preclinical Medical Device Testing Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need for validation and verification of medical devices
    • Favorable government initiatives and investments to develop healthcare infrastructure
    • Rapid demand for outsourcing medical device testing services
  • Market Restraints
    • Limited infrastructural setup and complex services
  • Market Opportunities
    • Development in IoT and AI in various medical devices
    • Technological advancements and innovations in medical device testing services
  • Market Challenges
    • Concerns regarding standardized overseas qualification tests

Porter's Five Forces: A Strategic Tool for Navigating the Preclinical Medical Device Testing Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Preclinical Medical Device Testing Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Preclinical Medical Device Testing Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Preclinical Medical Device Testing Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Preclinical Medical Device Testing Services Market

A detailed market share analysis in the Preclinical Medical Device Testing Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Preclinical Medical Device Testing Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Preclinical Medical Device Testing Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Preclinical Medical Device Testing Services Market

A strategic analysis of the Preclinical Medical Device Testing Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Preclinical Medical Device Testing Services Market, highlighting leading vendors and their innovative profiles. These include Bureau Veritas S.A., Charles River Laboratories, Inc., Eurofins Scientific (Ireland) Limited, Intertek Group PLC, Medistri SA, Nelson Labs NV, PaxeraHealth LLC, Pharmacology Discovery Services Taiwan, Ltd., SGS Societe Generale de Surveillance SA, Sipra Labs Limited, Sterigenics International LLC, TUV Rheinland AG, UL LLC, Viroclinics Biosciences, and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Preclinical Medical Device Testing Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service, market is studied across Antimicrobial Activity Testing, Bioburden Determination, Biocompatibility Test, Chemistry Test, Microbiology Test & Sterility, Pyrogen & Endotoxin Testing, and Sterility Test & Validation.
  • Based on Phase, market is studied across Antimicrobial Wound Dressings and Medical Coatings.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for validation and verification of medical devices
      • 5.1.1.2. Favorable government initiatives and investments to develop healthcare infrastructure
      • 5.1.1.3. Rapid demand for outsourcing medical device testing services
    • 5.1.2. Restraints
      • 5.1.2.1. Limited infrastructural setup and complex services
    • 5.1.3. Opportunities
      • 5.1.3.1. Development in IoT and AI in various medical devices
      • 5.1.3.2. Technological advancements and innovations in medical device testing services
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding standardized overseas qualification tests
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Preclinical Medical Device Testing Services Market, by Service

  • 6.1. Introduction
  • 6.2. Antimicrobial Activity Testing
  • 6.3. Bioburden Determination
  • 6.4. Biocompatibility Test
  • 6.5. Chemistry Test
  • 6.6. Microbiology Test & Sterility
  • 6.7. Pyrogen & Endotoxin Testing
  • 6.8. Sterility Test & Validation

7. Preclinical Medical Device Testing Services Market, by Phase

  • 7.1. Introduction
  • 7.2. Antimicrobial Wound Dressings
  • 7.3. Medical Coatings

8. Americas Preclinical Medical Device Testing Services Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Preclinical Medical Device Testing Services Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Preclinical Medical Device Testing Services Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bureau Veritas S.A.
  • 2. Charles River Laboratories, Inc.
  • 3. Eurofins Scientific (Ireland) Limited
  • 4. Intertek Group PLC
  • 5. Medistri SA
  • 6. Nelson Labs NV
  • 7. PaxeraHealth LLC
  • 8. Pharmacology Discovery Services Taiwan, Ltd.
  • 9. SGS Societe Generale de Surveillance SA
  • 10. Sipra Labs Limited
  • 11. Sterigenics International LLC
  • 12. TUV Rheinland AG
  • 13. UL LLC
  • 14. Viroclinics Biosciences
  • 15. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY ANTIMICROBIAL ACTIVITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY BIOBURDEN DETERMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY BIOCOMPATIBILITY TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY CHEMISTRY TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY MICROBIOLOGY TEST & STERILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PYROGEN & ENDOTOXIN TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY STERILITY TEST & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY ANTIMICROBIAL WOUND DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY MEDICAL COATINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 104. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023